Package 67850-141-05

Brand: asclera

Generic: polidocanol
NDC Package

Package Facts

Identity

Package NDC 67850-141-05
Digits Only 6785014105
Product NDC 67850-141
Product ID 67850-141_f443bbaf-ef8e-4f9e-ba4c-6f87dc58a671
Description

2 mL in 1 AMPULE (67850-141-05)

Marketing

Marketing Status
Marketed Since 2022-02-01
Brand asclera
Generic polidocanol
Sample Package No

Linked Drug Pages (1)

Asclera ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "f443bbaf-ef8e-4f9e-ba4c-6f87dc58a671", "openfda": {"nui": ["N0000175814", "N0000020024", "N0000009905"], "upc": ["0367850141056", "0367850140059"], "unii": ["0AWH8BFG9A"], "rxcui": ["968173", "968177", "968181", "968183"], "spl_set_id": ["bb1f342b-5352-4059-a0b2-e60fd652fd28"], "pharm_class_pe": ["Vascular Sclerosing Activity [PE]"], "pharm_class_epc": ["Sclerosing Agent [EPC]"], "pharm_class_moa": ["Sclerosing Activity [MoA]"], "manufacturer_name": ["Methapharm, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 AMPULE (67850-141-05)", "package_ndc": "67850-141-05", "marketing_start_date": "20220201"}], "brand_name": "Asclera", "product_id": "67850-141_f443bbaf-ef8e-4f9e-ba4c-6f87dc58a671", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Sclerosing Activity [MoA]", "Sclerosing Agent [EPC]", "Vascular Sclerosing Activity [PE]"], "product_ndc": "67850-141", "generic_name": "POLIDOCANOL", "labeler_name": "Methapharm, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Asclera", "active_ingredients": [{"name": "POLIDOCANOL", "strength": ".01 g/mL"}], "application_number": "NDA021201", "marketing_category": "NDA", "marketing_start_date": "20100601", "listing_expiration_date": "20261231"}